DePuy Synthes, a global leader in orthopaedic technologies and solutions, today announced the appointment of Christina ...

Johnson & Johnson’s DePuy Synthes Orthopaedics business today announced the appointment of Christina Zamarro as its new CFO.

Christina Zamarro will take over the role in July after spending nearly 20 years at Goodyear Tire & Rubber Company, most recently serving as its CFO.

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Synthes said on Monday it was in takeover talks with Johnson & Johnson , after reports the U.S. group is looking to buy the Swiss medical device maker for about $20 billion. A source familiar with the ...

Johnson & Johnson plans to spin off its orthopedics business into a standalone company. The move comes as part of a bid to focus J&J’s medical technology division on faster-growing areas. In an Oct.

ZURICH/NEW YORK (Reuters) - Johnson & Johnson will buy Swiss medical devices maker Synthes Inc for $21.67 billion, placing a big bet on growing its orthopedics business with one of the largest deals ...

Simply sign up to the US & Canadian companies myFT Digest -- delivered directly to your inbox. If Synthes is bought by Johnson & Johnson, it will dispel years of speculation about the plans of ...

Simply sign up to the US & Canadian companies myFT Digest -- delivered directly to your inbox. Fracture a bone anywhere in the world and the odds are good that Synthes will supply the materials to ...

Johnson & Johnson agreed to buy Synthes Inc. for $21.3 billion in the biggest purchase of the company’s 125-year history, to become the leader in the $5.5 billion market for devices that treat trauma ...